Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Huber

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Journal of Psychiatric Research|June 8, 2025
COVID-19 and lockdown: effects on coercion and length of stay for patients with personality disordersL Dinsenbacher, J S Krückl, L Imfeld, et al.
Planta Medica|January 30, 2007
Isolation and structural elucidation of 3',4',5'-trimethoxyflavone from the flowers of Primula verisC W Huck, C G Huber, I M Lagoja, et al.
Pharmacopsychiatry|September 3, 2008
Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorderM Lambert, C G Huber, D Naber, et al.
Planta Medica|May 25, 2016
Characterization of the XIAP-Inhibiting Proanthocyanidin Fraction of the Aerial Parts of Ephedra sinicaS Schäfer, S Salcher, M Seiter, et al.
Analytical Chemistry|June 14, 2001
High-performance liquid chromatography-electrospray ionization mass spectrometry using monolithic capillary columns for proteomic studiesA Premstaller, H Oberacher, W Walcher, et al.
Translational Psychiatry|March 25, 2015
Increased functional connectivity in the resting-state basal ganglia network after acute heroin substitutionA Schmidt, N Denier, S Magon, et al.
Immunobiology|June 14, 2001
Enhancement of complement-mediated lysis by a peptide derived from SCR 13 of complement factor HH Stoiber, C Ammann, M Spruth, et al.
Acta Psychiatrica Scandinavica|August 14, 2008
Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophreniaM Lambert, D Naber, A Schacht, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Journal of Psychiatric Research|June 8, 2025
COVID-19 and lockdown: effects on coercion and length of stay for patients with personality disordersL Dinsenbacher, J S Krückl, L Imfeld, et al.
Planta Medica|January 30, 2007
Isolation and structural elucidation of 3',4',5'-trimethoxyflavone from the flowers of Primula verisC W Huck, C G Huber, I M Lagoja, et al.
Pharmacopsychiatry|September 3, 2008
Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorderM Lambert, C G Huber, D Naber, et al.
Planta Medica|May 25, 2016
Characterization of the XIAP-Inhibiting Proanthocyanidin Fraction of the Aerial Parts of Ephedra sinicaS Schäfer, S Salcher, M Seiter, et al.
Analytical Chemistry|June 14, 2001
High-performance liquid chromatography-electrospray ionization mass spectrometry using monolithic capillary columns for proteomic studiesA Premstaller, H Oberacher, W Walcher, et al.
Translational Psychiatry|March 25, 2015
Increased functional connectivity in the resting-state basal ganglia network after acute heroin substitutionA Schmidt, N Denier, S Magon, et al.
Immunobiology|June 14, 2001
Enhancement of complement-mediated lysis by a peptide derived from SCR 13 of complement factor HH Stoiber, C Ammann, M Spruth, et al.
Acta Psychiatrica Scandinavica|August 14, 2008
Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophreniaM Lambert, D Naber, A Schacht, et al.
Pageof 6